http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2601141-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_df874e3cf88adba3792dc9d5b5776180
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37f4922dfb7777b019e504b885211b8e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-44
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-94
filingDate 1986-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b43b3e9db090c380d35893c13e3a7081
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d8f09bacf6d1cb2aad1d6b195991f7b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60e4e7bef21fd95ce8416e8aa2712ad5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb9d429ad9a0b19b87820451066d1fce
publicationDate 1988-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber FR-2601141-A1
titleOfInvention HAPTEN COUPLING PRODUCT, IN PARTICULAR AS AN IMMUNOGENIC SUBSTANCE, CORRESPONDING ANTIBODIES AND APPLICATIONS
abstract THE INVENTION RELATES TO A COUPLING PRODUCT, WITH THE HELP OF A BRIDGING AGENT, BETWEEN A CARRIER AND A HAPTENE, THE SKELETON OF WHICH HAS AT LEAST ONE CYCLE AND PRESENTS A NON-SUSBTITUTED EXOCYCLIC AMINO GROUP. THIS COUPLING PRODUCT IS USEFUL AS AN IMMUNOGENIC SUBSTANCE ALLOWING TO OBTAIN ANTIBODIES DIRECTED AGAINST HAPTENES OF THE SAME SKELETON AS THE ABOVE HAPTEN, BUT COMPRISING, IN PLACE OF THE REMAINDER AMINO EXOCYCLIC NOT SUBSTITUTED, A RESTE AMINO EXOCYCLIQUE SUBSTITUTE. THUS, MONOCLONAL AND POLYCLONAL ANTIBODIES RECOGNIZING THE AMINO-4-CHLORO-7 QUINOLEINE (ACQ) STRUCTURE, WHICH REPRESENTS THE SKELETON OF ANTIPALUDEAN DRUGS OF THE AMINO-4 QUINOLEINE TYPE, HAVE BEEN SOURCED FROM ACZ, FOLLOWING PATELLE HEMOCYANIN VIA GLUTARALDEHYDE. THE RESULTING ANTIBODIES PRESENT A DEFINED SPECIFICITY WITH RESPECT TO THIS HAPTEN, BUT REACT BETTER WITH SUBSTITUTE COMPOUNDS ON THE EXOCYCLIC AMINO GROUP IN POSITION 4.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5202270-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2775524-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5707844-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9429478-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006034235-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006034235-A3
priorityDate 1986-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0149405-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0104527-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0167256-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0123114-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0060081-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0165681-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0044441-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507775
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68476
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24341
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419530596
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426185410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9954069
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424876269
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2719
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6327
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533714
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424983022
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491057
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419486168
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3652
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7047
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522456
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID273781
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553237
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11953960
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485535
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2165
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID273781
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457673758
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10964
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526858
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3034034
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3485
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449460393
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID94711
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504623
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426105809
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID40692
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7860

Total number of triples: 64.